Insights and Stories on Bayer

Jun. 15, 2023 at 6:27 pm CDT

New York | Reuters — Bayer agreed on Thursday to pay US$6.9 million to settle claims by New York Attorney General Letitia James that it misled consumers by advertising Roundup, which has been linked to cancer, as environmentally safe. The settlement resolves accusations that Bayer and its Monsanto unit failed […]

By jonathan-stempel

Jan. 31, 2023 at 7:28 pm CST

Frankfurt | Reuters — A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace CEO Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development prospects, […]

By Ludwig Burger, Patricia Weiss

Jan. 10, 2023 at 3:53 pm CST

Reuters — Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources. U.K.-based Bluebell is also seeking an overhaul of Bayer’s corporate governance, the report added. A Bayer spokesperson, […]

By Reuters

Aug. 4, 2022 at 2:46 pm CDT

Frankfurt | Reuters – Agriculture and pharmaceuticals company Bayer BAYGn.DE on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special […]

By Ludwig Burger, Patricia Weiss

Jul. 7, 2022 at 6:00 pm CDT

Reuters — Bayer and BASF have won a new trial on US$60 million in punitive damages they were ordered to pay a Missouri peach farmer who said dicamba, a herbicide they produced, drifted onto his orchard and harmed his crops. The Eighth U.S. Circuit Court of Appeals found that a […]

By Brendan Pierson